Key result
Candesartan produced a significantly greater increase in renal plasma flow than captopril in white individuals (104.2 vs 52.4 ml/min; P=0.03), but not in black individuals (P=0.59).
Why the study?
Does the renal vascular response to captopril and candesartan differ between nondiabetic, normotensive black and white individuals?
Does the renal vascular response to captopril and candesartan differ between nondiabetic, normotensive black and white individuals?
There is an ACE-independent pathway for angiotensin II generation in the kidneys of nondiabetic, normotensive white individuals, but not black individuals.
Racial differences in renal response to ARB vs ACEI may exist; hypothesis-generating and should not guide therapy without prospective trials.
OBJECTIVE: We compared the renal vascular response to captopril and candesartan among nondiabetic, normotensive black and white participants to explore angiotensin-converting enzyme-independent generation of angiotensin II. METHODS: Thirteen black individuals and 10 white individuals in low-salt balance were given captopril and candesartan on sequential study days, and the renal plasma flow responses to these agents were measured. RESULTS: Consistent with our prior observations, white individuals demonstrated a strong, significant correlation between responses to these drugs (r = 0.78, P = 0.008) and a significantly greater increase in the renal plasma flow in response to candesartan compared with captopril (104.2 +/- 26.8 versus 52.4 +/- 24.3 ml/min per 1.73 m; P = 0.03). In black participants, however, no correlation between responses to captopril and to candesartan was observed (r = 0.22, P = 0.47) and there was no difference in the renal plasma flow response between the two drugs (90.4 +/- 13.0 versus 80.4 +/- 15.3 ml/min per 1.73 m; P = 0.59). The difference in the response to the two drugs was significantly higher among white participants compared with black participants (P = 0.03). CONCLUSION: We confirmed the contribution of an angiotensin-converting enzyme-independent pathway for angiotensin II generation in the kidneys of nondiabetic, normotensive white, but not black, individuals.
No takes yet. Share an insight, caveat, or question.
Forman et al. (2007) studied nondiabetic, normotensive (n=23). Candesartan vs. Captopril was evaluated on renal plasma flow response in white individuals (p=0.03). Candesartan produced a significantly greater increase in renal plasma flow than captopril in white individuals (104.2 vs 52.4 ml/min; P=0.03), but not in black individuals (P=0.59).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: